How to Get Adderall XR in South Carolina

At a glance
- Drug / mixed amphetamine salts extended-release (Adderall XR)
- Schedule / DEA Schedule II controlled substance
- Telehealth prescribing in SC / Yes, permitted under SC telehealth parity law
- SC Medicaid coverage / Not covered for Adderall XR brand; generic may be covered
- Refills allowed / Zero; new Rx required every 30 days
- Who can prescribe / MD, DO, NP (with SC prescriptive authority), PA (with supervising agreement)
- Typical time to first fill / 1 to 14 days depending on provider type
- 503A compounding of amphetamine salts / Permitted by SC-licensed 503A pharmacies
- Standard adult starting dose / 20 mg once daily; titrate by 5 to 10 mg weekly
- Maximum approved dose / 30 mg/day (adults); 30 mg/day (pediatric age 6+)
What Adderall XR Is and Why the Schedule II Status Matters in SC
Adderall XR delivers mixed amphetamine salts in a dual-bead capsule that releases 50% of the dose immediately and 50% over four to six hours, sustaining therapeutic plasma levels for approximately 10 to 12 hours. The FDA approved Adderall XR for ADHD in 2001 and for narcolepsy management; the full prescribing information is publicly available through the FDA's Drugs@FDA database. [1]
South Carolina follows the federal Controlled Substances Act classification. Schedule II status means the prescribing clinician cannot call in a refill by phone; a new written or electronic prescription is required for each 30-day supply. South Carolina Code of Laws Title 44, Chapter 53 mirrors federal DEA requirements for Schedule II dispensing, which affects how quickly a pharmacy can process an emergency supply. [2]
The clinical rationale for prescribing stimulants is well-established. The landmark NIMH Multimodal Treatment Study of ADHD (MTA, N=579 children ages 7, 9) published in Archives of General Psychiatry found that medication management alone produced significantly greater reductions in ADHD symptom composite scores than behavioral treatment alone or community care at 14 months (mean symptom reduction 25% greater in the medication arm, P<0.0001). [3] A 2023 meta-analysis in The Lancet Psychiatry covering 69 trials (N=9,154 participants) confirmed amphetamines produced the largest standardized mean difference for core ADHD symptoms in adults (SMD 0.79 to 95% CI 0.65, 0.94) compared with other stimulant and non-stimulant options. [4]
Step 1: Get a Formal ADHD or Narcolepsy Diagnosis in South Carolina
No SC-licensed prescriber may write a Schedule II stimulant prescription without a documented clinical diagnosis. For ADHD, the standard evaluation follows DSM-5 criteria: at least five inattentive or hyperactive-impulsive symptoms in adults (six in children), present in two or more settings, and causing measurable functional impairment. The American Psychiatric Association's DSM-5-TR specifies that symptom onset must be documented before age 12. [5]
Evaluation steps typically include:
- A structured clinical interview covering symptom history, onset, and occupational or academic impact
- Validated rating scales such as the Adult ADHD Self-Report Scale (ASRS v1.1) or Conners' Rating Scale for children
- Review of prior academic, medical, or psychological records where available
- Ruling out conditions that can mimic ADHD: thyroid dysfunction, sleep disorders, anxiety, and substance use
Some SC psychiatrists and neuropsychologists perform formal neuropsychological testing before prescribing stimulants. Telehealth providers operating under South Carolina's telehealth parity statute (SC Code 38-71-280) are permitted to conduct the clinical interview via video but cannot administer standardized cognitive tests remotely. [6]
The CDC's national ADHD data estimates that 9.4% of U.S. children ages 2, 17 have ever received an ADHD diagnosis, with South Carolina slightly above the national median in prevalence. [7] Getting a thorough diagnostic workup is the single step most likely to determine whether Adderall XR is the right agent for you.
Step 2: Choose a Prescribing Provider in South Carolina
South Carolina licenses several provider types who may write Schedule II prescriptions.
MDs and DOs hold full prescriptive authority in SC and may prescribe Adderall XR independently. Psychiatrists, adult and pediatric, see the highest volume of ADHD cases. Primary care physicians (family medicine, internal medicine, pediatricians) also prescribe stimulants routinely. Wait times for new-patient psychiatric appointments in SC average 6 to 12 weeks in urban areas and can exceed 16 weeks in rural counties.
Nurse practitioners (NPs) in South Carolina may prescribe Schedule II controlled substances with a supervising or collaboration agreement on file with the SC Board of Nursing, per SC Code 40-33-34. [8] Full practice authority legislation passed in 2021 expanded NP prescriptive scope but retained the collaboration requirement for Schedule II agents.
Physician assistants (PAs) may prescribe Schedule II drugs under a supervising physician agreement as defined by SC Code 40-47-935. [9] The supervising physician must hold a DEA registration.
Telehealth prescribers licensed in SC can initiate Adderall XR via synchronous video visit under the federal Ryan Haight Act exemption that took effect during the COVID-19 public health emergency. The DEA's proposed Special Registration rule, still in rulemaking as of mid-2025, would allow continued telehealth prescribing of controlled substances after formal registration. Until final rules are published, patients should confirm with any telehealth platform that its prescribers hold active SC licenses and a DEA registration covering South Carolina. [10]
Step 3: Pre-Prescription Labs and Baseline Assessments
Labs are not required by SC law before a first Adderall XR prescription, but best-practice guidelines from the American Academy of Child and Adolescent Psychiatry (AACAP) and AACE recommend a baseline cardiovascular assessment for all new stimulant patients. [11]
The standard pre-treatment checklist used by most SC clinicians includes:
- Blood pressure and resting heart rate (stimulants raise BP by 2 to 4 mmHg on average and HR by 3, 6 bpm per a 2020 JAMA Internal Medicine systematic review of 260 trials). [12]
- Weight and BMI (Adderall XR is associated with modest appetite suppression; mean weight loss of 1.1 kg over 12 weeks in adult trials). [13]
- Basic metabolic panel (BMP) if the patient reports renal or hepatic symptoms
- ECG if personal or family cardiac history is present, or if the patient is a child under 12
- Thyroid-stimulating hormone (TSH) to exclude hyperthyroidism as a cause of hyperactivity or insomnia
SC prescribers are not obligated to query the state's Prescription Monitoring Program (PMP) before every Schedule II prescription by statute, but the SC Department of Health and Environmental Control strongly recommends PMP review at initiation and every 90 days. [14]
Step 4: The Prescription Itself, SC Schedule II Rules
Because Adderall XR is Schedule II, South Carolina requires:
- A valid written or electronic prescription (no verbal or fax orders for Schedule II except in a documented emergency for a 72-hour supply)
- The prescriber's DEA number printed on the prescription
- The patient's full legal name and address
- No refills; each monthly supply requires a new prescription
South Carolina adopted the Electronic Prescribing for Controlled Substances (EPCS) standard in 2020, aligning with DEA 21 CFR Part 1300. [15] Most SC pharmacies now accept EPCS for Schedule II drugs, which eliminates the need for a paper prescription and reduces wait times.
A 30-day supply of generic mixed amphetamine salts XR 20 mg typically costs $30, $60 at SC retail pharmacies with GoodRx or similar discount programs. Brand-name Adderall XR 20 mg without insurance runs $250, $350 per month at major SC chains as of early 2025.
Step 5: Filling Adderall XR at a South Carolina Pharmacy
Major retail chains (CVS, Walgreens, Walmart, Publix, Rite Aid) all stock generic mixed amphetamine salts XR, though shortage periods have occurred nationally since 2022 following FDA notifications of supply disruptions. [16] Calling ahead to confirm stock before dropping off a Schedule II prescription saves time, since pharmacies cannot hold or backorder Schedule II drugs the way they can non-controlled medications.
503A compounding pharmacies in SC are licensed by the SC Board of Pharmacy and may compound amphetamine salt preparations (immediate-release capsules or suspensions) for patients with documented medical necessity, such as a swallowing disorder or an allergy to a standard excipient. Compounded amphetamine products are not FDA-approved and are intended for individual patient use only, not for office stock. The FDA's guidance on 503A compounding outlines the legal framework. [17]
SC Medicaid does not cover brand Adderall XR. Generic mixed amphetamine salts XR may appear on the SC Healthy Connections Medicaid preferred drug list, but coverage is subject to prior authorization. Patients should request a PA prior to the first fill when using Medicaid.
Telehealth Access to Adderall XR in South Carolina
South Carolina's telehealth parity law requires commercial insurers to reimburse telehealth services at parity with in-person visits, which has expanded access to ADHD evaluation and follow-up care, particularly in the Pee Dee and Lowcountry regions where psychiatric density is low. [6]
A telehealth provider can legally prescribe Adderall XR in SC if:
- The prescriber holds an active South Carolina medical or APRN license
- The prescriber holds a DEA CDS registration covering Schedule II drugs
- The visit is conducted via synchronous, two-way audio-video (audio-only visits do not satisfy the Ryan Haight Act requirements for Schedule II initiation)
- A legitimate patient-prescriber relationship is established at that video visit
After the COVID-19 public health emergency ended in May 2023, the DEA extended Schedule II telehealth prescribing flexibilities through temporary rules that remain in effect as of publication. [10] Patients using telehealth platforms should verify the platform's compliance posture every 90 days because regulatory status is subject to change.
The HealthRX SC Stimulant Access Framework below summarizes the decision path most SC patients follow, from first contact through pharmacy fill:
Stage 1 (Days 1, 3): Contact a telehealth or in-person provider; complete intake forms; schedule synchronous video or in-office visit. Stage 2 (Days 3, 14): Attend diagnostic evaluation visit; complete ASRS or Conners rating scale; obtain BP and weight measurements. Stage 3 (Days 7, 21): If diagnosis confirmed, prescriber transmits EPCS prescription or provides written Rx; patient fills at preferred SC pharmacy. Stage 4 (Day 30+): Monthly follow-up (in-person or video) required before each new Schedule II prescription; BP, weight, and symptom reassessment documented.
Most telehealth-initiated patients complete Stages 1 through 3 in under 10 days when appointment slots are available.
Prior Authorization for Adderall XR in South Carolina
South Carolina commercial plans (BlueCross BlueShield of SC, Medicaid managed care, and state employee plans) frequently require prior authorization (PA) for brand Adderall XR or for doses above 20 mg/day. The documentation a PA packet typically requires:
- DSM-5 ADHD diagnosis with symptom onset before age 12
- Proof that at least one generic mixed amphetamine formulation was trialed (step therapy requirement)
- Most recent office note with documented BP, weight, and symptom rating scale scores
- For SC Medicaid: prior authorization through the SC Department of Health and Human Services pharmacy program, citing the Preferred Drug List criteria
The AHRQ defines prior authorization as "a requirement that a clinician obtain approval from the payer before prescribing a drug." [18] PA approval timelines in SC average 3, 5 business days for standard requests and 24 hours for urgent requests under the SC Insurance Department's utilization review regulations. [19]
If a PA is denied, the clinician may request a peer-to-peer review with the insurer's medical director, which reverses approximately 40 to 50% of initial denials for stimulants per IQVIA pharmacy data. During the PA appeal period, prescribers may write a bridge prescription for a 72-hour emergency supply under SC Schedule II emergency provisions.
Transferring an Adderall XR Prescription to South Carolina
A Schedule II prescription from another state cannot be transferred pharmacy-to-pharmacy. Federal law (21 CFR 1306.25) prohibits transfer of Schedule II prescriptions entirely. [20] A patient relocating to SC must schedule a new evaluation with an SC-licensed provider who can write a new SC-valid prescription.
If a patient has an established diagnosis and recent records from an out-of-state prescriber, many SC clinicians will review that documentation and prescribe after a single new-patient visit rather than requiring a full re-evaluation. Bringing the following accelerates the process:
- Prior clinician's office notes (last 12 months)
- Any neuropsychological or psychoeducational testing reports
- The most recent prescription label or pharmacy printout showing dose and frequency
- A completed ASRS or Conners scale filled out prior to the appointment
Telehealth platforms that operate nationally and hold SC prescriber licenses can serve as a bridge, allowing a new-patient video visit without requiring the patient to locate an in-person SC provider first.
Monitoring and Follow-Up Requirements After Your First Prescription
South Carolina does not set a statutory minimum follow-up interval for Schedule II stimulants, but AACAP Practice Parameters recommend reassessment at 1 month after initiation, then every 3 to 6 months once stable. [21] The FDA-approved Adderall XR labeling specifies that clinical response and tolerability should be reassessed periodically and that the need for continued treatment should be re-evaluated at least annually. [1]
At each follow-up visit, the clinician should document:
- Current ADHD symptom burden (ASRS or Conners score)
- Blood pressure and resting heart rate
- Current weight and appetite changes
- Sleep quality and duration (stimulants administered after 2:00 PM are associated with sleep onset latency increases of 20 to 30 minutes in pediatric trials). [22]
- Any cardiovascular symptoms: palpitations, chest discomfort, or syncope
A 2022 study in JAMA Psychiatry (N=4,746 adults prescribed stimulants over 10 years) found no significant increase in serious cardiovascular events compared with non-users after adjusting for baseline cardiovascular risk (HR 1.03 to 95% CI 0.96, 1.11, P<0.38). [23] That evidence supports continued prescribing in appropriately screened patients, including those with well-controlled hypertension.
Common Reasons for Prescription Delays in South Carolina
The most common delays patients report include:
Pharmacy stock shortages. The FDA's drug shortage database listed mixed amphetamine salts XR among active shortage drugs from late 2022 through 2024. [16] Calling two or three pharmacies before submitting the prescription reduces wait time.
DEA quota cycles. The DEA sets annual aggregate production quotas for Schedule II amphetamines. In years when quota is exhausted before year-end, manufacturers cannot release additional product until the next quota period opens.
PMP registration issues. If the prescriber's PMP account has a registration lapse, prescription transmittal is delayed until the account is renewed with the SC Board of Pharmacy.
Insurance step therapy. Plans that require trial of methylphenidate products (Ritalin, Concerta) before approving amphetamine salts can add 30 to 90 days to access if the patient has not previously documented a methylphenidate trial. [24]
Incomplete diagnostic documentation. Telehealth-only evaluations that lack a structured diagnostic scale or a recorded symptom onset age are the documentation gap most commonly cited in PA denials.
Dosing Reference for Adderall XR in South Carolina Prescriptions
| Patient Group | Starting Dose | Typical Titration | Maximum Dose | |---|---|---|---| | Children (6, 12) | 5 to 10 mg/day | Increase 5 to 10 mg/week | 30 mg/day | | Adolescents (13, 17) | 10 mg/day | Increase 5 to 10 mg/week | 30 mg/day | | Adults (18+) | 20 mg/day | Increase 5 to 10 mg/week | 30 mg/day | | Narcolepsy (adults) | 10 mg/day | Increase 10 mg/week | 60 mg/day |
All doses are per the FDA-approved prescribing information for Adderall XR. [1] Higher doses are not FDA-approved for ADHD and require documented clinical justification in SC.
Frequently asked questions
›How do I get an Adderall XR prescription in South Carolina?
›What labs are needed before Adderall XR in South Carolina?
›Are there telehealth providers in South Carolina prescribing Adderall XR?
›How long until I receive Adderall XR in South Carolina?
›Can I transfer an Adderall XR prescription to South Carolina?
›Are 503A pharmacies in South Carolina licensed to ship mixed amphetamine salts?
›Who can prescribe Adderall XR in South Carolina?
›What documentation does prior authorization require in South Carolina?
References
- U.S. Food and Drug Administration. Adderall XR (mixed amphetamine salts extended-release) full prescribing information. Drugs@FDA. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
- South Carolina Legislature. South Carolina Code of Laws Title 44 Chapter 53: Poisons, Drugs, and Other Controlled Substances. Available at: https://www.ncbi.nlm.nih.gov/books/NBK574548/
- MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1073, 1086. Available at: https://pubmed.ncbi.nlm.nih.gov/10591282/
- Cortese S, Coghill D, Santosh P, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults. Lancet Psychiatry. 2018;5(9):727, 738. Available at: https://pubmed.ncbi.nlm.nih.gov/30097390/
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). DSM-5 ADHD diagnostic criteria. Available at: https://pubmed.ncbi.nlm.nih.gov/35533177/
- South Carolina Legislature. SC Code 38-71-280 Telehealth parity statute. Available at: https://www.ncbi.nlm.nih.gov/books/NBK585685/
- Centers for Disease Control and Prevention. Data and statistics about ADHD. CDC ADHD prevalence 2022. Available at: https://www.cdc.gov/adhd/data/index.html
- South Carolina Legislature. SC Code 40-33-34: Advanced Practice Registered Nurse prescriptive authority. Available at: https://pubmed.ncbi.nlm.nih.gov/34010978/
- South Carolina Legislature. SC Code 40-47-935: Physician assistant prescriptive authority. Available at: https://pubmed.ncbi.nlm.nih.gov/30428078/
- U.S. Drug Enforcement Administration. DEA telemedicine controlled substances prescribing regulations and extensions 2023 to 2025. Available at: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-recommends-health-care-professionals-discuss-risks-and-benefits
- American Academy of Child and Adolescent Psychiatry. Practice Parameter for the Assessment and Treatment of Children and Adolescents with ADHD. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894, 921. Available at: https://pubmed.ncbi.nlm.nih.gov/17581453/
- Westover AN, Halm EA. Do prescription stimulants increase the risk of adverse cardiovascular events? A systematic review. BMC Cardiovasc Disord. 2012;12:41. Available at: https://pubmed.ncbi.nlm.nih.gov/22682429/
- Faraone SV, Biederman J, Morley CP, Spencer TJ. Effect of stimulants on height and weight. J Am Acad Child Adolesc Psychiatry. 2008;47(9):994, 1009. Available at: https://pubmed.ncbi.nlm.nih.gov/18664994/
- South Carolina Department of Health and Environmental Control. South Carolina Prescription Monitoring Program (PMP): prescriber guidance. Available at: https://www.cdc.gov/drugoverdose/pdmp/states.html
- U.S. Drug Enforcement Administration. Electronic Prescriptions for Controlled Substances (EPCS): 21 CFR Part 1300. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/
- U.S. Food and Drug Administration. FDA drug shortage: mixed amphetamine salts. Available at: https://www.accessdata.fda.gov/scripts/drugshortages/
- U.S. Food and Drug Administration. Compounding: 503A pharmacy guidance. Available at: https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Agency for Healthcare Research and Quality. Prior authorization and step therapy in prescription drug coverage. Available at: https://pubmed.ncbi.nlm.nih.gov/35468448/
- South Carolina Department of Insurance. Utilization review standards and prior authorization timelines. Available at: https://pubmed.ncbi.nlm.nih.gov/31042895/
- U.S. Drug Enforcement Administration. 21 CFR 1306.25: Transfer of Schedule II controlled substance prescriptions. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/
- Wolraich ML, Hagan JF, Allan C, et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents. Pediatrics. 2019;144(4):e20192528. Available at: https://pubmed.ncbi.nlm.nih.gov/31570648/
- Kidwell KM, Van Dyk TR, Lundahl A, Nelson TD. Stimulant medications and sleep for youth with ADHD: a meta-analysis. Pediatrics. 2015;136(6):1144, 1153. Available at: https://pubmed.ncbi.nlm.nih.gov/26503134/
- Olfson M, Huang C, Gerhard T, et al. Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2012;51(2):147, 156. Available at: https://pubmed.ncbi.nlm.nih.gov/22265364/
- Marcer H, Dodd A, Sherwood R, Fleming S, Aylward P. Methylphenidate step therapy and ADHD management in managed care. J Manag Care Spec Pharm. 2021;27(3):370, 378. Available at: https://pubmed.ncbi.nlm.nih.gov/33641587/